Biblio

Found 14 results
Filters: Keyword is Genetic Predisposition to Disease  [Clear All Filters]
2021
Wilson RB, Vangala S, Elashoff D, Safari T, Smith BA.  2021.  Using Wearable Sensor Technology to Measure Motion Complexity in Infants at High Familial Risk for Autism Spectrum Disorder.. Sensors (Basel). 21(2)
2015
Tartter M, Hammen C, Bower JE, Brennan PA, Cole S.  2015.  Effects of chronic interpersonal stress exposure on depressive symptoms are moderated by genetic variation at IL6 and IL1β in youth.. Brain Behav Immun. 46:104-11.
2014
Carpenter KM, Eisenberg S, Weltfreid S, Low CA, Beran T, Stanton AL.  2014.  Characterizing biased cancer-related cognitive processing: relationships with BRCA1/2 genetic mutation status, personal cancer history, age, and prophylactic surgery.. Health Psychol. 33(9):1003-11.
Slavich GM, Tartter MA, Brennan PA, Hammen C.  2014.  Endogenous opioid system influences depressive reactions to socially painful targeted rejection life events.. Psychoneuroendocrinology. 49:141-9.
2013
Bower JE, Ganz PA, Irwin MR, Castellon S, Arevalo J, Cole SW.  2013.  Cytokine genetic variations and fatigue among patients with breast cancer.. J Clin Oncol. 31(13):1656-61.
2012
Vodermaier A, Stanton AL.  2012.  Familial breast cancer: less emotional distress in adult daughters if they provide emotional support to their affected mother.. Fam Cancer. 11(4):645-52.
2011
Cole SW, Arevalo JMG, Manu K, Telzer EH, Kiang L, Bower JE, Irwin MR, Fuligni AJ.  2011.  Antagonistic pleiotropy at the human IL6 promoter confers genetic resilience to the pro-inflammatory effects of adverse social conditions in adolescence.. Dev Psychol. 47(4):1173-80.
2008
Low CA, Bower JE, Kwan L, Seldon J.  2008.  Benefit finding in response to BRCA1/2 testing.. Ann Behav Med. 35(1):61-9.
Collado-Hidalgo A, Bower JE, Ganz PA, Irwin MR, Cole SW.  2008.  Cytokine gene polymorphisms and fatigue in breast cancer survivors: early findings.. Brain Behav Immun. 22(8):1197-200.
Beran TM, Stanton AL, Kwan L, Seldon J, Bower JE, Vodermaier A, Ganz PA.  2008.  The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal? Ann Behav Med. 36(2):107-16.
2007
O'Connor M-F, Irwin MR, Seldon J, Kwan L, Ganz PA.  2007.  Pro-inflammatory cytokines and depression in a familial cancer registry.. Psychooncology. 16(5):499-501.
2006
Taylor SE, Way BM, Welch WT, Hilmert CJ, Lehman BJ, Eisenberger NI.  2006.  Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology.. Biol Psychiatry. 60(7):671-6.
1999
Siegel JM.  1999.  Narcolepsy: a key role for hypocretins (orexins). Cell. 98(4):409-12.
1993
Mignot E, Nishino S, Sharp LH, Arrigoni J, Siegel JM, Reid MS, Edgar DM, Ciaranello RD, Dement WC.  1993.  Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems.. J Neurosci. 13(3):1057-64.